Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
| 363 | 3 | RENIN ANGIOTENSIN SYSTEM//ANGIOTENSIN II//BRADYKININ | 35741 |
| 2089 | 2 | HEREDITARY ANGIOEDEMA//ANGIOEDEMA//C1 INHIBITOR | 5570 |
| 32667 | 1 | TRANDOLAPRIL//VERAPAMIL SR TRANDOLAPRIL COMBINATION THERAPY//VERAPAMIL TRANDOLAPRIL | 148 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | TRANDOLAPRIL | authKW | 2651597 | 28% | 30% | 41 |
| 2 | VERAPAMIL SR TRANDOLAPRIL COMBINATION THERAPY | authKW | 425905 | 1% | 100% | 2 |
| 3 | VERAPAMIL TRANDOLAPRIL | authKW | 425905 | 1% | 100% | 2 |
| 4 | 24H ABP | authKW | 212953 | 1% | 100% | 1 |
| 5 | ANGIOTERISIN CONVERTING ENZYME ACE | authKW | 212953 | 1% | 100% | 1 |
| 6 | ATENOLOL CHLORTHALIDONE | authKW | 212953 | 1% | 100% | 1 |
| 7 | BETA BLOCKER DIURETIC COMBINATION | authKW | 212953 | 1% | 100% | 1 |
| 8 | CALCIUM ANTAGONIST ANGIOTENSIN CONVERTING ENZYME INHIBITOR COMBINATION | authKW | 212953 | 1% | 100% | 1 |
| 9 | CARDIOVASCULAR AND RENAL PROTECTIVE EFFECTS | authKW | 212953 | 1% | 100% | 1 |
| 10 | DIURNAL BLOOD PRESSURE EFFECTS | authKW | 212953 | 1% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Peripheral Vascular Diseases | 1117 | 26% | 0% | 38 |
| 2 | Cardiac & Cardiovascular System | 987 | 32% | 0% | 48 |
| 3 | Pharmacology & Pharmacy | 803 | 43% | 0% | 64 |
| 4 | Toxicology | 47 | 6% | 0% | 9 |
| 5 | Medicine, Research & Experimental | 42 | 7% | 0% | 11 |
| 6 | Medicine, General & Internal | 36 | 9% | 0% | 13 |
| 7 | Health Policy & Services | 6 | 1% | 0% | 2 |
| 8 | Geriatrics & Gerontology | 6 | 1% | 0% | 2 |
| 9 | Primary Health Care | 5 | 1% | 0% | 1 |
| 10 | Health Care Sciences & Services | 3 | 1% | 0% | 2 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | INVEST BIOMED AUGUSTO PI SURIER | 212953 | 1% | 100% | 1 |
| 2 | UNITAT HYPERTENSIO | 212953 | 1% | 100% | 1 |
| 3 | ALBERT E EIN MED HOSP | 53237 | 1% | 25% | 1 |
| 4 | MED CARE INTERNAL MED | 53237 | 1% | 25% | 1 |
| 5 | CHINA FRONTAGE USA | 35490 | 1% | 17% | 1 |
| 6 | CO 11 | 35490 | 1% | 17% | 1 |
| 7 | HYPERTENS DIS SECT | 35488 | 1% | 8% | 2 |
| 8 | PARTNERINGCARE SENIOR SERV | 30420 | 1% | 14% | 1 |
| 9 | AL MYASNIKOV CLIN CARDIOL | 30416 | 2% | 5% | 3 |
| 10 | CHAIR POLYCLIN THER Y | 26617 | 1% | 13% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE | 5264 | 4% | 0% | 6 |
| 2 | JOURNAL OF HUMAN HYPERTENSION | 4606 | 6% | 0% | 9 |
| 3 | JOURNAL OF DRUG DEVELOPMENT AND CLINICAL PRACTICE | 4174 | 1% | 2% | 1 |
| 4 | AMERICAN JOURNAL OF HYPERTENSION | 3532 | 7% | 0% | 10 |
| 5 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 3253 | 9% | 0% | 13 |
| 6 | CARDIOVASCULAR THERAPY AND PREVENTION | 2567 | 2% | 0% | 3 |
| 7 | DRUGS | 2379 | 5% | 0% | 8 |
| 8 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 2172 | 5% | 0% | 7 |
| 9 | ADVANCES IN THERAPY | 1096 | 2% | 0% | 3 |
| 10 | CLINICAL THERAPEUTICS | 1045 | 3% | 0% | 5 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |